Revenue (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	2022		2021		2020
Biologics	41	%	41	%	31	%
Generics	18	%	17	%	20	%
Pharma	24	%	24	%	26	%
Contract-Manufactured Products	17	%	18	%	23	%
	100	%	100	%	100	%

The following table presents the approximate percentage of our net sales by product category:

	2022		2021		2020
High-Value Product Components	55	%	54	%	46	%
High-Value Product Delivery Devices	5	%	5	%	5	%
Standard Packaging	23	%	23	%	26	%
Contract-Manufactured Products	17	%	18	%	23	%
	100	%	100	%	100	%

The following table presents the approximate percentage of our net sales by geographic location:

	2022		2021		2020
Americas	48	%	45	%	48	%
Europe, Middle East, Africa	43	%	45	%	43	%
Asia Pacific	9	%	10	%	9	%
	100	%	100	%	100	%

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2021	$	14.6
Contract assets, December 31, 2022	16.3
Change in contract assets - increase (decrease)	$	1.7
Deferred income, December 31, 2021	$	(61.3)
Deferred income, December 31, 2022	(68.2)
Change in deferred income - (increase) decrease	$	(6.9)